Inspire Medical Systems, Inc. $INSP Shares Sold by Amundi

Key Points

• Amundi cut its Inspire Medical Systems stake by 95.1% in the second quarter, selling 244,278 shares and retaining 12,552 shares valued at approximately $560,000. Institutional investors overall own 94.91% of the company.
• Inspire reported quarterly EPS of $0.14, beating estimates of a $0.24 loss, while revenue reached $200.58 million. However, revenue declined 7.6% year over year, and the company issued fiscal 2026 EPS guidance of $1.05–$1.45.
• Analyst sentiment remains mixed, with the stock carrying a consensus “Hold” rating and a $66.50 target price. Shares opened at $72.73, above the consensus target but well below their 52-week high of $147.03.

Amundi reduced its position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 95.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,552 shares of the company's stock after selling 244,278 shares during the quarter. Amundi's holdings in Inspire Medical Systems were worth $560,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC grew its stake in shares of Inspire Medical Systems by 1,115.4% in the first quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company's stock valued at $33,000 after buying an additional 580 shares in the last quarter. Havemeyer Place LP purchased a new stake in shares of Inspire Medical Systems during the fourth quarter valued at approximately $39,000. Versant Capital Management Inc raised its stake in shares of Inspire Medical Systems by 379.0% during the second quarter. Versant Capital Management Inc now owns 958 shares of the company's stock valued at $43,000 after purchasing an additional 758 shares during the period. GAMMA Investing LLC lifted its position in shares of Inspire Medical Systems by 85.0% during the second quarter. GAMMA Investing LLC now owns 1,221 shares of the company's stock worth $54,000 after purchasing an additional 561 shares in the last quarter. Finally, Hantz Financial Services Inc. lifted its position in shares of Inspire Medical Systems by 194.0% during the fourth quarter. Hantz Financial Services Inc. now owns 685 shares of the company's stock worth $63,000 after purchasing an additional 452 shares in the last quarter. Hedge funds and other institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Stock Down 2.5%

Shares of NYSE:INSP opened at $72.73 on Thursday. The company's 50-day moving average price is $58.57 and its 200 day moving average price is $52.87. The company has a market cap of $2.10 billion, a PE ratio of 15.74, a P/E/G ratio of 5.67 and a beta of 0.70. Inspire Medical Systems, Inc. has a fifty-two week low of $38.91 and a fifty-two week high of $147.03.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.14 EPS for the quarter, beating the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The company had revenue of $200.58 million for the quarter, compared to analyst estimates of $194.72 million. During the same quarter last year, the business earned $0.45 earnings per share. Inspire Medical Systems's revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. As a group, equities analysts anticipate that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Piper Sandler lifted their price objective on Inspire Medical Systems from $55.00 to $60.00 and gave the stock a "neutral" rating in a report on Tuesday, August 4th. Bank of America cut Inspire Medical Systems from a "neutral" rating to an "underperform" rating and set a $39.00 target price for the company. in a research note on Friday, May 22nd. Evercore set a $54.00 price target on shares of Inspire Medical Systems in a research report on Tuesday, August 4th. Zacks Research upgraded shares of Inspire Medical Systems from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 17th. Finally, Royal Bank Of Canada reiterated a "sector perform" rating and set a $60.00 price objective on shares of Inspire Medical Systems in a research note on Tuesday, August 4th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, Inspire Medical Systems presently has an average rating of "Hold" and a consensus target price of $66.50.

Insider Buying and Selling at Inspire Medical Systems

In other news, insider Jason Kelly sold 963 shares of the company's stock in a transaction on Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the completion of the sale, the insider owned 18,985 shares in the company, valued at $1,130,556.75. This represents a 4.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 2.20% of the stock is currently owned by company insiders.

About Inspire Medical Systems

Inspire Medical Systems, Inc develops and commercializes medical devices for treating moderate to severe obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company's primary product is Inspire therapy, an implantable system designed for patients who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses a small implantable pulse generator, a breathing-sensing lead and a stimulation lead.

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.